Plant-based Vaccine Manufacturing System Developed

The Fraunhofer Center for Molecular Biotechnology (CMB), the Fraunhofer Center for Manufacturing Innovation (CMI), the Boston University College of Engineering, and the biopharmaceutical company iBio have recently developed a fully-automated pharmaceutical plant which can make huge amounts of vaccines in weeks. This brand new system does not use genetically modified plants but instead it uses plant viral vector technology wherein specific proteins can be grown swiftly within the leaves of the plant. The factory uses robotics in sowing seeds, nurturing plants, and harvesting protein-induced plant biomass for vaccines.

This new technology has been reported to produce tens of thousands of plants in one batch with fewer expenses compared to traditional methods. Chemical engineer Robert Brown, president of Boston University, stressed that this new plant-based protein production system is a perfect model of combining engineering skill and scientific innovation to efficiently solve the health need of the society.

Visit http://www.genengnews.com/gen-news-highlights/plant-based-protein-production-system-developed/78565322/ for more details.